drugset / Trial / NCT03999684
A Trial of All-trans Retinoic Acid (ATRA) in Advanced Adenoid Cystic Carcinoma
Phase 2
Completed
18 enrolled
Dana-Farber Cancer Institute
Adenoid Cystic Carcinoma Research Foundation · collabThe V Foundation · collab
NaSingle-groupOpen-labelTreatment
Summary
This research is studying how safe and effective all-trans retinoic acid (ATRA), is to treat advanced adenoid cystic carcinoma (ACC).
Timeline
- Start
- 2019-08-05
- Primary completion
- 2020-04-15
- Completion
- 2020-04-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tretinoin | Small molecule | — | Oral |